Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Myung Lee
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Living Beings
Concepts & Ideas
Procedures
Anatomy
Chemicals & Drugs
Phenomena
Disorders
Sign-in to see full Profile
Network (preview)
30
Bae, Soo
28
Kwon, Jong
24
Lee, Inchul
21
Kim, Won Bae
20
Kim, Yu
19
Lee, Joo
18
Kim, Sang
15
Kim, So
15
Kim, Eun
15
Choi, Young
11
Kim, Yoon
11
Lee, Dae
9
Shim, Hyun
8
Yang, Si
8
Kim, Jin
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Myung Lee (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Jung Hye Y; Kang Hee E; Choi Young H; Kim So H; Lee Myung G
Time-dependent effects of Klebsiella pneumoniae endotoxin on the pharmacokinetics of chlorzoxazone and its main metabolite, 6-hydroxychlorzoxazone, in rats: restoration of the parameters in 96 hour in KPLPS rats to control levels.
Biopharmaceutics & drug disposition 2009;30(8):485-93.
-
2009: Kang Hee E; Jung Hye Y; Cho Yu K; Kim So H; Sohn Se I; Baek Seung R; Lee Myung G
Pharmacokinetics of liquiritigenin in mice, rats, rabbits, and dogs, and animal scale-up.
Journal of pharmaceutical sciences 2009;98(11):4327-42.
-
2009: Choi Young H; Lee Young S; Kim Tae K; Lee Bong-Y; Lee Myung G
Faster clearance of mirodenafil in rats with acute renal failure induced by uranyl nitrate: contribution of increased protein expression of hepatic CYP3A1 and intestinal CYP1A1 and 3A1/2.
The Journal of pharmacy and pharmacology 2009;61(10):1325-32.
-
2009: Choi Young H; Lee Young S; Bae Soo H; Kim Tae K; Lee Bong-Y; Lee Myung G
Dose-dependent pharmacokinetics and first-pass effects of mirodenafil, a new erectogenic, in rats.
Biopharmaceutics & drug disposition 2009;30(6):305-17.
-
2009: Chung Hye J; Kang Hee E; Yang Kyung H; Kim Sung Y; Lee Myung G
Ipriflavone pharmacokinetics in mutant Nagase analbuminemic rats.
Biopharmaceutics & drug disposition 2009;30(6):294-304.
-
2009: Lee Dae Y; Jung Young S; Kim Young C; Kim Sung Y; Lee Myung G
Faster clearance of omeprazole in mutant Nagase analbuminemic rats: possible roles of increased protein expression of hepatic CYP1A2 and lower plasma protein binding.
Biopharmaceutics & drug disposition 2009;30(3):107-16.
-
2009: Bae Soo K; Yang Kyung H; Aryal Dipendra K; Kim Yoon G; Lee Myung G
Pharmacokinetics of amitriptyline and one of its metabolites, nortriptyline, in rats: little contribution of considerable hepatic first-pass effect to low bioavailability of amitriptyline due to great intestinal first-pass effect.
Journal of pharmaceutical sciences 2009;98(4):1587-601.
-
2009: Yang Kyung H; Choi Young H; Lee Unji; Lee Joo H; Lee Myung G
Effects of cytochrome P450 inducers and inhibitors on the pharmacokinetics of intravenous furosemide in rats: involvement of CYP2C11, 2E1, 3A1 and 3A2 in furosemide metabolism.
The Journal of pharmacy and pharmacology 2009;61(1):47-54.
-
2008: Lee Joo H; Cho Yu K; Jung Young S; Kim Young C; Lee Myung G
Time-dependent effects of Klebsiella pneumoniae endotoxin on the telithromycin pharmacokinetics in rats; restoration of the parameters in 96-hour KPLPS rats to the control levels.
Pulmonary pharmacology & therapeutics 2008;21(6):860-5.
-
2008: Choi Young H; Lee Duck C; Lee Inchul; Lee Myung G
Changes in metformin pharmacokinetics after intravenous and oral administration to rats with short-term and long-term diabetes induced by streptozotocin.
Journal of pharmaceutical sciences 2008;97(12):5363-75.
-
2008: Chung Hye J; Kang Hee E; Bae Eun J; Lee Inchul; Kim Sang G; Lee Myung G
Effects of E. Coli lipopolysaccharide on the pharmacokinetics of ipriflavone and its metabolites, M1 and M5, after intravenous and oral administration of ipriflavone to rats: decreased metabolism of ipriflavone due to decreased expression of hepatic CYP1A2 and 2C11.
Journal of pharmaceutical sciences 2008;97(11):5024-36.
-
2008: Yang Si H; Lee Myung G
Dose-independent pharmacokinetics of ondansetron in rats: contribution of hepatic and intestinal first-pass effects to low bioavailability.
Biopharmaceutics & drug disposition 2008;29(7):414-26.
-
2008: Yang Si H; Yang Kyung H; Lee Myung G
Gender differences in ondansetron pharmacokinetics in rats.
Biopharmaceutics & drug disposition 2008;29(7):406-13.
-
2008: Lee Joo H; Lee Myung G
Telithromycin pharmacokinetics in rat model of diabetes mellitus induced by alloxan or streptozotocin.
Pharmaceutical research 2008;25(8):1915-24.
-
2008: Yang Si H; Lee Myung G
Effects of cytochrome P450 (CYP) inducers and inhibitors on ondansetron pharmacokinetics in rats: involvement of hepatic CYP2D subfamily and 3A1/2 in ondansetron metabolism.
The Journal of pharmacy and pharmacology 2008;60(7):853-61.
-
2008: Lee Dae Y; Jung Young S; Shin Hyun S; Lee Inchul; Kim Young C; Lee Myung G
Faster clearance of omeprazole in rats with acute renal failure induced by uranyl nitrate: contribution of increased expression of hepatic cytochrome P450 (CYP) 3A1 and intestinal CYP1A and 3A subfamilies.
The Journal of pharmacy and pharmacology 2008;60(7):843-51.
-
2008: Ahn Choong Y; Bae Soo K; Jung Young S; Lee Inchul; Kim Young C; Lee Myung G; Shin Wan G
Pharmacokinetic parameters of chlorzoxazone and its main metabolite, 6-hydroxychlorzoxazone, after intravenous and oral administration of chlorzoxazone to liver cirrhotic rats with diabetes mellitus.
Drug metabolism and disposition: the biological fate of chemicals 2008;36(7):1233-41.
-
2008: Yang Kyung H; Jung Young S; Lee Dae Y; Lee Joo H; Kim Young C; Lee Myung G
Time-dependent effects of Klebsiella pneumoniae endotoxin (KPLPS) on the pharmacokinetics of theophylline in rats: return of the parameters in 96-hour KPLPS rats to the control levels.
Drug metabolism and disposition: the biological fate of chemicals 2008;36(5):811-5.
-
2008: Lee Joo H; Cho Yu K; Jung Young S; Kim Young C; Lee Myung G
Effects of Escherichia coli lipopolysaccharide on telithromycin pharmacokinetics in rats: inhibition of metabolism via CYP3A.
Antimicrobial agents and chemotherapy 2008;52(3):1046-51.
-
2008: Choi Young H; Lee Inchul; Lee Myung G
Effects of cysteine on metformin pharmacokinetics in rats with protein-calorie malnutrition: partial restoration of some parameters to control levels.
The Journal of pharmacy and pharmacology 2008;60(2):153-61.
-
2008: Yang Kyung H; Lee Joo H; Lee Myung G
Effects of CYP inducers and inhibitors on the pharmacokinetics of intravenous theophylline in rats: involvement of CYP1A1/2 in the formation of 1,3-DMU.
The Journal of pharmacy and pharmacology 2008;60(1):45-53.
-
2008: Kim Yu C; Kang Hee E; Lee Myung G
Pharmacokinetics of phenytoin and its metabolite, 4'-HPPH, after intravenous and oral administration of phenytoin to diabetic rats induced by alloxan or streptozotocin.
Biopharmaceutics & drug disposition 2008;29(1):51-61.
-
2008: Lee Myung G; Choi Young H; Lee Inchul
Effects of diabetes mellitus induced by alloxan on the pharmacokinetics of metformin in rats: restoration of pharmacokinetic parameters to the control state by insulin treatment.
Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Société canadienne des sciences pharmaceutiques 2008;11(1):88-103.
-
2007: Lee Dae Y; Kim Jin W; Lee Myung G
Pharmacokinetic interaction between oltipraz and omeprazole in rats: Competitive inhibition of metabolism of oltipraz by omeprazole via CYP1A1 and 3A2, and of omeprazole by oltipraz via CYP1A1/2, 2D1/2, and 3A1/2.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2007;32(4-5):328-39.
-
2007: Choi Hye D; Kang Hee E; Chung Hye J; Bae Soo K; Shin Karen N; Lee Myung G
Effects of water deprivation on the pharmacokinetics of theophylline and one of its metabolites, 1,3-dimethyluric acid, after intravenous and oral administration of aminophylline to rats.
Biopharmaceutics & drug disposition 2007;28(8):445-54.
-
2007: Choi Young H; Bae Soo K; Oh Jung M; Kim Sun-Ok; Lee Myung G
Pharmacokinetics of intravenous methotrexate in mutant Nagase analbuminemic rats.
Biopharmaceutics & drug disposition 2007;28(7):385-92.
-
2007: Choi Young H; Lee Inchul; Lee Myung G
Effects of water deprivation on the pharmacokinetics of metformin in rats.
Biopharmaceutics & drug disposition 2007;28(7):373-83.
-
2007: Bae Soo K; Yang Si H; Shin Karen N; Rhee Jae K; Yoo Moohi; Lee Myung G
Pharmacokinetics of DA-7218, a new oxazolidinone, and its active metabolite, DA-7157, after intravenous and oral administration of DA-7218 and DA-7157 to rats.
The Journal of pharmacy and pharmacology 2007;59(7):955-63.
-
2007: Choi Young H; Lee Inchul; Lee Myung G
Effects of bacterial lipopolysaccharide on the pharmacokinetics of metformin in rats.
International journal of pharmaceutics 2007;337(1-2):194-201.
-
2007: Lee Joo H; Lee Myung G
Effects of acute renal failure on the pharmacokinetics of telithromycin in rats: negligible effects of increase in CYP3A1 on the metabolism of telithromycin.
Biopharmaceutics & drug disposition 2007;28(4):157-66.
-
2007: Chung Hye J; Lee Joo H; Woo Sung J; Park Hee K; Koo Chang H; Lee Myung G
Pharmacokinetics of L-FMAUS, a new antiviral agent, after intravenous and oral administration to rats: contribution of gastrointestinal first-pass effect to low bioavailability.
Biopharmaceutics & drug disposition 2007;28(4):187-97.
-
2007: Choi Young H; Bae Soo K; Kim Sun O; Lee Myung G
Pharmacokinetics of 5-fluorouracil in mutant Nagase analbuminemic rats: faster metabolism of 5-fluorouracil via CYP1A.
Biopharmaceutics & drug disposition 2007;28(2):87-95.
-
2007: Yang Si H; Lee Myung G
Dose-independent pharmacokinetics of clindamycin after intravenous and oral administration to rats: contribution of gastric first-pass effect to low bioavailability.
International journal of pharmaceutics 2007;332(1-2):17-23.
-
2007: Lee Dae Y; Lee Inchul; Lee Myung G
Pharmacokinetics of omeprazole after intravenous and oral administration to rats with liver cirrhosis induced by dimethylnitrosamine.
International journal of pharmaceutics 2007;330(1-2):37-44.
-
2007: Lee Dae Y; Lee Inchul; Lee Myung G
Effects of cysteine on the pharmacokinetic parameters of omeprazole in rats with protein-calorie malnutrition: partial restoration of some parameters to control levels by oral cysteine supplementation.
JPEN. Journal of parenteral and enteral nutrition 2007;31(1):37-46.
-
2007: Lee Dae Young; Lee Myung G; Shin Hyun Sook; Lee Inchul
Changes in omeprazole pharmacokinetics in rats with diabetes induced by alloxan or streptozotocin: faster clearance of omeprazole due to induction of hepatic CYP1A2 and 3A1.
Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Société canadienne des sciences pharmaceutiques 2007;10(4):420-33.
-
2006: Choi Young H; Kim Sang G; Lee Myung G
Dose-independent pharmacokinetics of metformin in rats: Hepatic and gastrointestinal first-pass effects.
Journal of pharmaceutical sciences 2006;95(11):2543-52.
-
2006: Lee Dae Y; Shin Hyun S; Lee Inchul; Lee Myung G
Pharmacokinetics of omeprazole in rats with water deprivation for 72 hours.
Biopharmaceutics & drug disposition 2006;27(8):361-70.
-
2006: Baek Hye W; Bae Soo K; Lee Myung G; Sohn Young T
Pharmacokinetics of chlorzoxazone in rats with diabetes: Induction of CYP2E1 on 6-hydroxychlorzoxazone formation.
Journal of pharmaceutical sciences 2006;95(11):2452-62.
-
2006: Chung Hye J; Lee Myung G
Pharmacokinetic changes of ipriflavone in rats with acute renal failure induced by uranyl nitrate.
Biopharmaceutics & drug disposition 2006;27(7):345-51.
-
2006: Shin Hyun S; Bae Soo K; Lee Myung G
Pharmacokinetics of sildenafil after intravenous and oral administration in rats: hepatic and intestinal first-pass effects.
International journal of pharmaceutics 2006;320(1-2):64-70.
-
2006: Lee Dae Y; Shin Hyun S; Bae Soo K; Lee Myung G
Effects of enzyme inducers and inhibitors on the pharmacokinetics of intravenous omeprazole in rats.
Biopharmaceutics & drug disposition 2006;27(5):209-18.
-
2006: Bae Soo K; Lee Shin J; Kim Taekrho; Kim Jin W; Lee Inchul; Kim Sang G; Lee Myung G
Pharmacokinetics and therapeutic effects of oltipraz after consecutive or intermittent oral administration in rats with liver cirrhosis induced by dimethylnitrosamine.
Journal of pharmaceutical sciences 2006;95(5):985-97.
-
2006: Bae Soo K; Kang Hee E; Kang Min K; Kim Jin W; Kim Taekrho; Lee Myung G
Pharmacokinetics of oltipraz in mutant Nagase analbuminemic rats.
Journal of pharmaceutical sciences 2006;95(5):998-1005.
-
2006: Chung Hye J; Choi Young H; Kim So H; Lee Myung G
Effects of enzyme inducers and inhibitors on the pharmacokinetics of intravenous ipriflavone in rats.
The Journal of pharmacy and pharmacology 2006;58(4):449-57.
-
2006: Bae Soo K; Kim Yu C; Lee Jae K; Kwon Jong W; Yoo Moohi; Lee Inchul; Lee Myung G
Effects of water deprivation for 72 hours on the pharmacokinetics of DA-7867, a new oxazolidinone, in rats.
Biopharmaceutics & drug disposition 2006;27(3):147-56.
-
2006: Lee Joo H; Kim Eun J; Kwon Jong W; Yoo Moohi; Lee Myung G
Negligible pharmacokinetic interaction between oral DA-8159, a new erectogenic, and amlodipine in rats.
Biopharmaceutics & drug disposition 2006;27(3):125-31.
-
2006: Kwak Hyun H; Kim Jong O; Chung Han K; Choi Seul M; Kim Jung H; Kwon Jong W; Yoo Moohi; Lee Joo H; Lee Myung G
Pharmacokinetics of oral amlodipine orotate in vagotomized dogs.
Biopharmaceutics & drug disposition 2006;27(3):141-5.
-
2006: Chung Hye J; Choi Young H; Choi Hye D; Jang Ji M; Shim Hyun J; Yoo Moohi; Kwon Jong W; Lee Myung G
Pharmacokinetics of DA-6034, an agent for inflammatory bowel disease, in rats and dogs: Contribution of intestinal first-pass effect to low bioavailability in rats.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2006;27(4):363-74.
-
2006: Kim Yu C; Oh Eun Y; Kim So H; Lee Myung G
Pharmacokinetics of diclofenac in rat model of diabetes mellitus induced by alloxan or steptozotocin.
Biopharmaceutics & drug disposition 2006;27(2):85-92.
-
2006: Choi Ka Y; Kim Yu C; Lee Myung G
Mechanism of enhanced bioavailability and diuretic effect of azosemide by ascorbic acid in rats.
Life sciences 2006;78(10):1057-62.
-
2006: Kim Eun J; Chung Mi Y; Chung Hye J; Son Mi W; Kwon Jong W; Yoo Moohi; Lee Myung G
Pharmacokinetics of 7-carboxymethyloxy-3',4',5-trimethoxy flavone (DA-6034), a derivative of flavonoid, in mouse and rat models of chemically-induced inflammatory bowel disease.
The Journal of pharmacy and pharmacology 2006;58(1):27-35.
-
2006: Bae Soo K; Kwon Jong W; Kim Won B; Lee Inchul; Lee Myung G
Effects of acute renal failure on the pharmacokinetics of DA-7867, a new oxazolidinone, in rats.
Biopharmaceutics & drug disposition 2006;27(1):29-37.
-
2006: Yang Si H; Bae Soo K; Kwon Jong W; Yoo Moohi; Lee Myung G
Gender differences in the pharmacokinetics of DA-6034, a derivative of flavonoids, in rats.
Biopharmaceutics & drug disposition 2006;27(1):47-51.
-
2005: Lee Joo H; Bae Soo K; Kwon Jong W; Kim Won B; Lee Myung G
Effects of omeprazole or cola beverage on the pharmacokinetics of oral DA-8159, a new erectogenic, in rats.
Biopharmaceutics & drug disposition 2005;26(9):411-6.
-
2005: Kim Yu C; Oh Eun Y; Kim So H; Lee Myung G
Pharmacokinetics and pharmacodynamics of intravenous torasemide in diabetic rats induced by alloxan or streptozotocin.
Biopharmaceutics & drug disposition 2005;26(8):371-8.
-
2005: Kim Yu C; Shim Hyun J; Lee Joo H; Kim Dong S; Kwon Jong W; Kim Won B; Lee Inchul; Lee Myung G
Pharmacokinetic changes of DA-8159, a new erectogenic, and one of its metabolites, DA-8164 after intravenous and oral administration of DA-8159 to spontaneously hypertensive rats and DOCA-salt-induced hypertensive rats.
Biopharmaceutics & drug disposition 2005;26(7):309-20.
-
2005: Shim Hyun J; Kim Yu C; Lee Joo H; Kwon Jong W; Kim Won B; Kim Yoon G; Kim So H; Lee Myung G
Interspecies pharmacokinetic scaling of DA-8159, a new erectogenic, in mice, rats, rabbits and dogs, and prediction of human pharmacokinetics.
Biopharmaceutics & drug disposition 2005;26(7):269-77.
-
2005: Kim Yu C; Shim Hyun J; Lee Joo H; Kim Soon H; Kwon Jong W; Kim Won B; Lee Myung G
Effects of enzyme inducers and inhibitors on the pharmacokinetics of intravenous DA-8159, a new erectogenic, in rats.
Biopharmaceutics & drug disposition 2005;26(6):233-41.
-
2005: Bae Soo K; Yang Si H; Kim Jin W; Kim Taekrho; Kwon Jong W; Lee Myung G
Effects of cysteine on the pharmacokinetics of oltipraz in rats with protein-calorie malnutrition.
Journal of pharmaceutical sciences 2005;94(7):1484-93.
-
2005: Lee Dae Y; Lee Shin J; Lee Myung G
Effects of enzyme inducers and inhibitors on the pharmacokinetics of intravenous torasemide in rats.
International journal of pharmaceutics 2005;298(1):38-46.
-
2005: Lee Dae Y; Kim Ji Y; Kim Yu C; Kwon Jong W; Kim Won B; Lee Myung G
Dose-independent pharmacokinetics of torasemide after intravenous and oral administration to rats.
Biopharmaceutics & drug disposition 2005;26(5):173-82.
-
2005: Kim Yu C; Lee Joo H; Kim So H; Lee Myung G
Effect of CYP3A1(23) induction on clarithromycin pharmacokinetics in rats with diabetes mellitus.
Antimicrobial agents and chemotherapy 2005;49(6):2528-32.
-
2005: Bae Soo K; Yang Si H; Lee Shin J; Kwon Jong W; Kim Won B; Lee Duk C; Lee Myung G
Pharmacokinetic changes of DA-7867, a new oxazolidinone, after intravenous and oral administration to rats with short-term and long-term diabetes mellitus induced by streptozotocin.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2005;25(2-3):337-45.
-
2005: Lee Joo H; Kim Yu C; Kwon Jong W; Kim Won B; Lee Myung G
Pharmacokinetics of DA-8159, a new erectogenic, administered at 10:00 h versus 22:00 h in rats.
International journal of pharmaceutics 2005;296(1-2):94-102.
-
2005: Shim Hyun J; Kim Yu C; Lee Joo H; Park Kyung J; Kwon Jong W; Kim Won B; Lee Myung G
Species differences in the formation of DA-8164 after intravenous and/or oral administration of DA-8159, a new erectogenic, to mice, rats, rabbits, dogs and humans.
Biopharmaceutics & drug disposition 2005;26(4):161-6.
-
2005: Bae Soo K; Kim Jin W; Kim Young H; Kim Yoon G; Kim Sang G; Lee Myung G
Hepatic and intestinal first-pass effects of oltipraz in rats.
Biopharmaceutics & drug disposition 2005;26(4):129-34.
-
2005: Bae Soo K; Lee Shin J; Kim Yoon G; Kim So H; Kim Jin W; Kim Taekrho; Lee Myung G
Interspecies pharmacokinetic scaling of oltipraz in mice, rats, rabbits and dogs, and prediction of human pharmacokinetics.
Biopharmaceutics & drug disposition 2005;26(3):99-115.
-
2005: Choi Young H; Lee Ae K; Bae Soo K; Kim Sun O; Lee Myung G
Pharmacokinetics of 5-fluorouracil in rats with diabetes mellitus induced by streptozotocin.
Biopharmaceutics & drug disposition 2005;26(3):93-8.
-
2005: Bae Soo K; Kim Eun J; Kwon Jong W; Kim Won B; Lee Inchul; Lee Myung G
Excretion and metabolism of DA-7867, a new oxazolidinone, in rats.
Biopharmaceutics & drug disposition 2005;26(2):67-75.
-
2005: Bae Soo K; Lee Shin J; Kim Jin W; Kim Young H; Kim Sang G; Lee Myung G
Pharmacokinetics of oltipraz after intravenous and oral administration in rats with dehydration for 72 hours.
Biopharmaceutics & drug disposition 2005;26(2):77-83.
-
2005: Lee Joo H; Kim Yu C; Kwon Jong W; Kim Won B; Lee Myung G
Effects of bacterial lipopolysaccharide on the pharmacokinetics of DA-8159, a new erectogenic, in rats.
Research communications in molecular pathology and pharmacology 2005;117-118():179-87.
-
2004: Shim Hyun J; Kim Yu C; Lee Joo H; Ahn Byung O; Kwon Jong W; Kim Won B; Lee Inchul; Lee Myung G
Pharmacokinetics of intravenous and oral DA-8159, a new erectogenic, in rats with protein-calorie malnutrition.
The Journal of pharmacy and pharmacology 2004;56(12):1543-50.
-
2004: Lee Ae K; Lee Joo H; Kwon Jong W; Kim Won B; Kim Sang G; Kim So H; Lee Myung G
Pharmacokinetics of clarithromycin in rats with acute renal failure induced by uranyl nitrate.
Biopharmaceutics & drug disposition 2004;25(6):273-82.
-
2004: Bae Soo K; Lee Dae Y; Lee Ae K; Kwon Jong W; Lee Inchul; Chung Suk-J; Kim Sang G; Shim Chang-K; Lee Myung G
Effects of cysteine on the pharmacokinetics of intravenous torasemide in rats with protein-calorie malnutrition.
Journal of pharmaceutical sciences 2004;93(9):2388-98.
-
2004: Kim Yu C; Kwon Jong W; Kim Won B; Lee Inchul; Lee Myung G
Pharmacokinetic changes of DA-8159, a new erectogenic, after intravenous and oral administration to rats with diabetes mellitus induced by streptozotocin.
Journal of pharmaceutical sciences 2004;93(9):2374-87.
-
2004: Bae Soo K; Lee Shin J; Kwon Jong W; Kim Won B; Lee Inchul; Lee Myung G
Effects of bacterial lipopolysaccharide on the pharmacokinetics of DA-7867, a new oxazolidinone, in rats.
Journal of pharmaceutical sciences 2004;93(9):2364-73.
-
2004: Bae Soo K; Lee Shin J; Kim Jin W; Kim Young H; Kim Sang G; Lee Myung G
Effects of acute renal failure on the pharmacokinetics of oltipraz in rats.
Journal of pharmaceutical sciences 2004;93(9):2353-63.
-
2004: Kim Yu C; Lee Myung G; Ko Seong-Hee; Kim So H
Effect of intravenous infusion time on the pharmacokinetics and pharmacodynamics of the same total dose of torasemide in rabbits.
Biopharmaceutics & drug disposition 2004;25(5):211-8.
-
2004: Shin Jee H; Choi Ka Y; Kim Yu C; Lee Myung G
Dose-dependent pharmacokinetics of itraconazole after intravenous or oral administration to rats: intestinal first-pass effect.
Antimicrobial agents and chemotherapy 2004;48(5):1756-62.
-
2004: Bae Soo K; Lee Shin J; Lee Jang Y; Lee Youngsoo; Lee Inchul; Kim Sang G; Lee Myung G
Pharmacokinetic changes of oltipraz after intravenous and oral administration to rats with liver cirrhosis induced by dimethylnitrosamine.
International journal of pharmaceutics 2004;275(1-2):227-38.
-
2004: Kim Sun-O; Kwak Sang-H; Lee Byung H; Lee Dong-H; Lim Hong; Yoo Sung-E; Chung Hye J; Lee Myung G
Dose-dependent pharmacokinetics of KR-31378, a new neuroprotective agent for ischaemia-reperfusion damage in dogs.
Biopharmaceutics & drug disposition 2004;25(3):143-8.
-
2004: Shim Hyun J; Kim Yu C; Kim Eun J; Kim Dong G; Kwon Jong W; Kim Won B; Lee Myung G
Pharmacokinetic changes of DA-8159, a new erectogenic, after intravenous and oral administration to rats with acute renal failure induced by uranyl nitrate.
Biopharmaceutics & drug disposition 2004;25(3):137-42.
-
2004: Bae Soo K; Chung Won-S; Kim Eun J; Rhee Jae K; Kwon Jong W; Kim Won B; Lee Myung G
Pharmacokinetics, blood partition and protein binding of DA-7867, a new oxazolidinone.
Biopharmaceutics & drug disposition 2004;25(3):127-35.
-
2004: Bae Soo K; Chung Won-Suk; Kim Eun J; Rhee Jae K; Kwon Jong W; Kim Won B; Lee Myung G
Pharmacokinetics of DA-7867, a new oxazolidinone, after intravenous or oral administration to rats: intestinal first-pass effect.
Antimicrobial agents and chemotherapy 2004;48(2):659-62.
-
2004: Lee Joo H; Shin Jee H; Lee Myung G
Pharmacokinetics, blood partition, and tissue distribution of itraconazole.
Research communications in molecular pathology and pharmacology 2004;115-116():203-15.
-
2004: Lee Eun J; Kim Eun J; Kim Yoon G; Chung Hye C; Kim So H; Kim Dong H; Lees Inchul; Kim Sang G; Lee Myung G
Effects of acute renal failure induced by uranyl nitrate on the pharmacokinetics of 2-(allylthio) pyrazine, a chemoprotective agent, in rats: the role of CYP3A23 induction.
Research communications in molecular pathology and pharmacology 2004;115-116():111-21.
-
2003: Shim Hyun J; Kim Yu C; Jang Ji M; Park Kyung J; Kim Dong H; Kang Kyung K; Ahn Byoung O; Kwon Jong W; Kim Won B; Lee Myung G
Subacute toxicities and toxicokinetics of DA-8159, a new phosphodiesterase type V inhibitor, after single and 4-week repeated oral administration in rats.
Biopharmaceutics & drug disposition 2003;24(9):409-18.
-
2003: Shim Hyun J; Kim Yu C; Park Kyung J; Kim Dong S; Kwon Jong W; Kim Won B; Lee Myung G
Pharmacokinetics of DA-8159, a new erectogenic, after intravenous and oral administration to rats: hepatic and intestinal first-pass effects.
Journal of pharmaceutical sciences 2003;92(11):2185-95.
-
2003: Suh Ok K; Kim So H; Lee Myung G
Pharmacokinetics and pharmacodynamics of azosemide.
Biopharmaceutics & drug disposition 2003;24(7):275-97.
-
2003: Ahn Choong Y; Kim Eun J; Kwon Jong W; Chung Suk J; Kim Sang G; Shim Chang-K; Lee Myung G
Effects of cysteine on the pharmacokinetics of intravenous clarithromycin in rats with protein-calorie malnutrition.
Life sciences 2003;73(14):1783-94.
-
2003: Ahn Choong Y; Kim Eun J; Lee Inchul; Kwon Jong W; Kim Won B; Kim Sang G; Lee Myung G
Effects of glucose on the pharmacokinetics of intravenous chlorzoxazone in rats with acute renal failure induced by uranyl nitrate.
Journal of pharmaceutical sciences 2003;92(8):1604-13.
-
2003: Kim Eun J; Bae Soo K; Kim Hee J; Kim Yoon G; Kim Sun-O; Lee Dong H; Lim Hong; Lee Myung G
Dose-independent pharmacokinetics of a candidate for diabetic neuropathy, SR-4668, after intravenous and oral administration to rats: Intestinal first-pass effect.
Journal of pharmaceutical sciences 2003;92(5):1112-24.
-
2003: Lee Ae K; Ahn Choong Y; Kim Eun J; Kwon Jong W; Kim Sang G; Chung Suk J; Shim Chang-K; Lee Myung G
Effects of cysteine on the pharmacokinetics of itraconazole in rats with protein-calorie malnutrition.
Biopharmaceutics & drug disposition 2003;24(2):63-70.
-
2003: Kim Yu C; Kim Yoon G; Kim Eun J; Cho Min K; Kim Sang G; Lee Myung G
Pharmacokinetics of intravenous chlorzoxazone in rats with dehydration and rehydration: effects of food intakes.
Biopharmaceutics & drug disposition 2003;24(2):53-61.
-
2003: Kim Eun J; Lee Ae K; Kim So H; Kim Sang G; Lee Myung G
Pharmacokinetics and pharmacodynamics of intravenous azosemide in mutant Nagase analbuminemic rats.
Drug metabolism and disposition: the biological fate of chemicals 2003;31(2):194-201.
-
2003: Kim Eun J; Lee Myung G
Pharmacokinetics and pharmacodynamics of intravenous trasemide in mutant Nagase analbuminemic rats.
Biopharmaceutics & drug disposition 2003;24(1):27-35.
-
2003: Kim Yoon G; Kim Sang K; Kwon Jong W; Park Ock J; Kim Sang G; Kim Young C; Lee Myung G
Effects of cysteine on amino acid concentrations and transsulfuration enzyme activities in rat liver with protein-calorie malnutrition.
Life sciences 2003;72(10):1171-81.
-
2003: Lee Mi H; Bae Soo K; Kim Eun J; Kim Yoon G; Kim Sun-O; Lee Dong H; Lim Hong; Yoo Sung-E; Lee Myung G
Dose-independent pharmacokinetics of a new neuroprotective agent for ischemia-reperfusion damage, KR-31543, after intravenous and oral administration to rats: hepatic and intestinal first-pass effects.
Journal of pharmaceutical sciences 2003;92(1):190-201.
-
2003: Lee Ae K; Kim Eun J; Lee Myung G
Effects of acute renal failure induced by uranyl nitrate on the pharmacokinetics of intravenous torasemide in rats.
Research communications in molecular pathology and pharmacology 2003;113-114():193-200.
-
2002: Kim Hee J; Lee Ae K; Kim Yoon G; Bu Seong C; Kim So H; Yang Chae H; Suh Ok Kyung; Kim Sang G; Lee Myung G
Influence of 4-week and 8-week exercise training on the pharmacokinetics and pharmacodynamics of intravenous and oral azosemide in rats.
Life sciences 2002;70(19):2299-319.
-
2002: Lee Eun J; Kim Eun J; Kim Yoon G; Chung Hye C; Kim So H; Kim Dong H; Lee Inchul; Kim Sang G; Lee Myung G
Pharmacokinetic changes of intravenous 2-(allylthio) pyrazine, a chemoprotective agent, in rats with acute renal failure induced by uranyl nitrate.
Research communications in molecular pathology and pharmacology 2002;111(5-6):225-36.
-
2000: Son I J; Moon Y J; Lee M G; Sohn Y T
Pharmacokinetic changes of intravenous tacrolimus in rats with uranyl nitrate-induced acute renal failure.
Research communications in molecular pathology and pharmacology 2000;108(5-6):359-68.
-
2000: Son I J; Moon Y J; Lee M G; Sohn Y T
No effect of water deprivation for 48 hours on the pharmacokiinetics of intravenous tacrolimus in rats.
Research communications in molecular pathology and pharmacology 2000;107(3-4):279-89.
Sign-in to see more
